Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MannKind (NNFN) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:NNFNMannKindCHF 3.32CHF 1.07B-16.77-2.21%Strong BuyUnlock the CH:NNFN analyst price target with TipRanks PremiumCH:NNFNUnlock the CH:NNFN top-analyst price target with TipRanks Premium
LXRXLexicon Pharmaceuticals$1.67$743.54M-11.4915.17%Strong BuyUnlock the LXRX analyst price target with TipRanks PremiumCH:NNFN vs LXRXUnlock the LXRX top-analyst price target with TipRanks Premium
INVAInnoviva$18.41$1.31B7.25-13.45%Strong BuyUnlock the INVA analyst price target with TipRanks PremiumCH:NNFN vs INVAUnlock the INVA top-analyst price target with TipRanks Premium
SVRASavara$5.21$1.15B-8.5413.26%Strong BuyUnlock the SVRA analyst price target with TipRanks PremiumCH:NNFN vs SVRAUnlock the SVRA top-analyst price target with TipRanks Premium
XERSXeris Pharmaceuticals$16.62$3.04B-414.46134.41%Strong BuyUnlock the XERS analyst price target with TipRanks PremiumCH:NNFN vs XERSUnlock the XERS top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:NNFNMannKind3.32-0.07-2.21%
LXRXLexicon Pharmaceuticals1.670.3526.52%
INVAInnoviva18.41-2.75-13.00%
SVRASavara5.210.5411.56%
XERSXeris Pharmaceuticals16.629.78142.98%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts